APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,668 | -72.2% | 149 | -33.5% | 0.00% | -50.0% |
Q2 2023 | $20,406 | +12.1% | 224 | -18.8% | 0.00% | 0.0% |
Q1 2023 | $18,205 | +24.8% | 276 | -2.1% | 0.00% | 0.0% |
Q4 2022 | $14,582 | -27.1% | 282 | -5.4% | 0.00% | -33.3% |
Q3 2022 | $20,000 | +300.0% | 298 | +195.0% | 0.00% | +200.0% |
Q2 2022 | $5,000 | 0.0% | 101 | +8.6% | 0.00% | 0.0% |
Q1 2022 | $5,000 | +150.0% | 93 | +144.7% | 0.00% | – |
Q4 2021 | $2,000 | +100.0% | 38 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | -50.0% | 38 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 38 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 38 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 38 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |